{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:09:58Z","timestamp":1793315398587,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T00:00:00Z","timestamp":1409184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"funder":[{"name":"NIH\/NIAID","award":["1R01AI073450"],"award-info":[{"award-number":["1R01AI073450"]}]},{"name":"NIH\/NIAID","award":["1P01AI090935"],"award-info":[{"award-number":["1P01AI090935"]}]}],"content-domain":{"domain":["cgfr.co.uk","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.cytogfr.2014.08.004","type":"journal-article","created":{"date-parts":[[2014,8,24]],"date-time":"2014-08-24T12:15:10Z","timestamp":1408882510000},"page":"669-679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Message in a bottle: lessons learned from antagonism of STING signalling during RNA virus infection"],"prefix":"10.1016","volume":"25","author":[{"given":"Kevin","family":"Maringer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Fernandez-Sesma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2014.08.004_bib0005","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cytogfr.2007.06.023","article-title":"RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity","volume":"18","author":"Yoneyama","year":"2007","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0010","first-page":"879","article-title":"Type 1 interferons and the virus\u2013host relationship: a lesson in detente","volume":"312","author":"Garcia-Sastre","year":"2006","journal-title":"Sci Rep"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0015","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0020","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.immuni.2008.09.003","article-title":"The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation","volume":"29","author":"Zhong","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0025","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1073\/pnas.0900850106","article-title":"ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization","volume":"106","author":"Sun","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0030","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.imbio.2013.07.007","article-title":"The interferon response to intracellular DNA: why so many receptors?","volume":"218","author":"Unterholzner","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0035","first-page":"1","article-title":"MITA\/STING: a central and multifaceted mediator in innate immune response","author":"Ran","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0040","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nature08476","article-title":"STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity","volume":"461","author":"Ishikawa","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0045","doi-asserted-by":"crossref","first-page":"e1002934","DOI":"10.1371\/journal.ppat.1002934","article-title":"DENV inhibits type I IFN production in infected cells by cleaving human STING","volume":"8","author":"Aguirre","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.26017","article-title":"Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity","volume":"57","author":"Nitta","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0055","doi-asserted-by":"crossref","first-page":"e30802","DOI":"10.1371\/journal.pone.0030802","article-title":"Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling","volume":"7","author":"Sun","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0060","doi-asserted-by":"crossref","first-page":"e1002780","DOI":"10.1371\/journal.ppat.1002780","article-title":"Dengue virus targets the adaptor protein MITA to subvert host innate immunity","volume":"8","author":"Yu","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jhep.2013.03.019","article-title":"Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity","volume":"59","author":"Ding","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s13238-014-0026-3","article-title":"SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex","volume":"5","author":"Chen","year":"2014","journal-title":"Protein Cell"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0075","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1099\/vir.0.051169-0","article-title":"The papain-like protease of porcine epidemic diarrhea virus negatively regulates type I interferon pathway by acting as a viral deubiquitinase","volume":"94","author":"Xing","year":"2013","journal-title":"J Gen Virol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0080","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.immuni.2012.03.019","article-title":"Structural analysis of the STING adaptor protein reveals a hydrophobic dimer interface and mode of cyclic di-GMP binding","volume":"36","author":"Ouyang","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0085","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.immuni.2010.10.013","article-title":"The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA","volume":"33","author":"Tsuchida","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0090","doi-asserted-by":"crossref","first-page":"28646","DOI":"10.1074\/jbc.M112.362608","article-title":"TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA\/STING protein for K63-linked ubiquitination","volume":"287","author":"Zhang","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.molcel.2013.01.039","article-title":"STING recognition of cytoplasmic DNA instigates cellular defense","volume":"50","author":"Abe","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2009.01.001","article-title":"Antiviral defense: RIG-Ing the immune system to STING","volume":"20","author":"Bowzard","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0105","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ni1087","article-title":"The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses","volume":"5","author":"Yoneyama","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0110","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nature12862","article-title":"Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity","volume":"505","author":"Schoggins","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0115","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0120","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ni.2350","article-title":"Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING","volume":"13","author":"Holm","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0125","first-page":"786","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0130","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature12305","article-title":"Structural mechanism of cytosolic DNA sensing by cGAS","volume":"498","author":"Civril","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5501\/wjv.v2.i2.32","article-title":"Architecture and biogenesis of plus-strand RNA virus replication factories","volume":"2","author":"Paul","year":"2013","journal-title":"World J Virol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0140","first-page":"1102","article-title":"Flaviviridae: the viruses and their replication","volume":"vol. I","author":"Lindenbach","year":"2007"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0145","doi-asserted-by":"crossref","first-page":"11418","DOI":"10.1128\/JVI.01257-06","article-title":"Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis","volume":"80","author":"Clyde","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0150","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1038\/nm1144","article-title":"Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses","volume":"10","author":"Mackenzie","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0155","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1016\/j.vaccine.2011.09.114","article-title":"Flaviviruses and flavivirus vaccines","volume":"30","author":"Heinz","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0160","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0165","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrmicro1006","article-title":"Transmission cycles, host range, evolution and emergence of arboviral disease","volume":"2","author":"Weaver","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0170","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/CMR.11.3.480","article-title":"Dengue and dengue hemorrhagic fever","volume":"11","author":"Gubler","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0175","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(12)61510-4","article-title":"Dengue vaccine development: a 75% solution?","volume":"380","author":"Halstead","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/2051013613507862","article-title":"Latest developments and future directions in dengue vaccines","volume":"2","author":"Thisyakorn","year":"2014","journal-title":"Ther Adv Vaccines"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0185","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S1286-4579(00)01258-2","article-title":"Dengue viral infections pathogenesis and epidemiology","volume":"2","author":"McBride","year":"2000","journal-title":"Microbes Infect"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0190","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1128\/JVI.02514-09","article-title":"Dengue virus inhibits the production of type I interferon in primary human dendritic cells","volume":"84","author":"Rodriguez-Madoz","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0195","doi-asserted-by":"crossref","first-page":"9760","DOI":"10.1128\/JVI.01051-10","article-title":"Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex","volume":"84","author":"Rodriguez-Madoz","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0200","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/gene.2010.75","article-title":"Identification and characterization of a loss-of-function human MPYS variant","volume":"12","author":"Jin","year":"2011","journal-title":"Genes Immun"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0205","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4269\/ajtmh.1952.1.51","article-title":"Propagation of dengue virus strains in unweaned mice","volume":"1","author":"Meiklejohn","year":"1952","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/v4010062","article-title":"Animal models of dengue virus infection","volume":"4","author":"Zompi","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0215","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.chom.2010.10.007","article-title":"Mouse STAT2 restricts early dengue virus replication","volume":"8","author":"Ashour","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0220","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.1128\/JVI.00062-06","article-title":"Murine model for dengue virus-induced lethal disease with increased vascular permeability","volume":"80","author":"Shresta","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0225","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","article-title":"Flavivirus genome organization, expression, and replication","volume":"44","author":"Chambers","year":"1990","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0230","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1042\/BJ20061136","article-title":"Cleavage preference distinguishes the two-component NS2B\u2013NS3 serine proteinases of Dengue and West Nile viruses","volume":"401","author":"Shiryaev","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep00347","article-title":"STING mediates neuronal innate immune response following Japanese encephalitis virus infection","volume":"2","author":"Nazmi","year":"2012","journal-title":"Sci Rep"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0240","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.dci.2014.03.001","article-title":"Identification, characterization and immunological response analysis of stimulator of interferon gene (STING) from grass carp Ctenopharyngodon idella","volume":"45","author":"Feng","year":"2014","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0245","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.dci.2010.03.005","article-title":"Molecular cloning and functional characterization of porcine stimulator of interferon genes (STING)","volume":"34","author":"Xie","year":"2010","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.coi.2009.01.007","article-title":"Antiviral immunity in drosophila","volume":"21","author":"Kemp","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0255","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","article-title":"The global burden of hepatitis C","volume":"29","author":"Lavanchy","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0260","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jmb.2013.10.032","article-title":"Activation and evasion of antiviral innate immunity by hepatitis C virus","volume":"426","author":"Horner","year":"2014","journal-title":"J Mol Biol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0265","first-page":"1254","article-title":"Hepatitis C virus","volume":"vol. I","author":"Lemon","year":"2007"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0270","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.12.010","article-title":"Immune responses to HCV and other hepatitis viruses","volume":"40","author":"Park","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0275","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nm.3183","article-title":"Current progress in development of hepatitis C virus vaccines","volume":"19","author":"Liang","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0280","doi-asserted-by":"crossref","first-page":"8499","DOI":"10.1073\/pnas.0602957103","article-title":"Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms","volume":"103","author":"Cheng","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0285","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s12072-007-9003-8","article-title":"Interferon-beta is activated by hepatitis C virus NS5B and inhibited by NS4A, NS4B, and NS5A","volume":"1","author":"Moriyama","year":"2007","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0290","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1099\/vir.0.83056-0","article-title":"Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I\/Cardif-induced interferon response","volume":"88","author":"Tasaka","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0295","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nature04193","article-title":"Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus","volume":"437","author":"Meylan","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0300","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1128\/JVI.01659-08","article-title":"MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3\/4A protease","volume":"83","author":"Baril","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0305","doi-asserted-by":"crossref","first-page":"17717","DOI":"10.1073\/pnas.0508531102","article-title":"Hepatitis C virus protease NS3\/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity","volume":"102","author":"Li","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0310","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature07106","article-title":"Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA","volume":"454","author":"Saito","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0315","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2011.01.009","article-title":"New opportunities in anti-hepatitis C virus drug discovery: targeting NS4B","volume":"90","author":"Rai","year":"2011","journal-title":"Antivir Res"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0320","first-page":"826","article-title":"Coronaviridae","volume":"vol. I","author":"Masters","year":"2013"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0325","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1128\/JVI.03488-13","article-title":"Coronaviruses: important emerging human pathogens","volume":"88","author":"Coleman","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0330","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00001432-200312000-00009","article-title":"Potential for antiviral treatment of severe acute respiratory syndrome","volume":"16","author":"Davidson","year":"2003","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0335","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mib.2014.05.005","article-title":"To sense or not to sense viral RNA \u2013 essentials of coronavirus innate immune evasion","volume":"20","author":"Kindler","year":"2014","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0340","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0345","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.1128\/JVI.01049-10","article-title":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice","volume":"84","author":"Zhao","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0350","doi-asserted-by":"crossref","first-page":"32208","DOI":"10.1074\/jbc.M704870200","article-title":"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus","volume":"282","author":"Devaraj","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0355","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1128\/JVI.02406-09","article-title":"Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases","volume":"84","author":"Clementz","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0360","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1073\/pnas.0510851103","article-title":"Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme","volume":"103","author":"Ratia","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0365","doi-asserted-by":"crossref","first-page":"15199","DOI":"10.1128\/JVI.79.24.15199-15208.2005","article-title":"The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme","volume":"79","author":"Lindner","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0370","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.abb.2007.07.006","article-title":"Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease","volume":"466","author":"Lindner","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0375","doi-asserted-by":"crossref","first-page":"15189","DOI":"10.1128\/JVI.79.24.15189-15198.2005","article-title":"The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity","volume":"79","author":"Barretto","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0380","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1099\/vir.0.059014-0","article-title":"Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease","volume":"95","author":"Yang","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0385","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/cr.2008.294","article-title":"PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production","volume":"18","author":"Zheng","year":"2008","journal-title":"Cell Res"},{"key":"10.1016\/j.cytogfr.2014.08.004_bib0390","doi-asserted-by":"crossref","first-page":"e17192","DOI":"10.1371\/journal.pone.0017192","article-title":"PLP2 of mouse hepatitis virus A59 (MHV-A59) targets TBK1 to negatively regulate cellular type I interferon signaling pathway","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS ONE"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610114000872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610114000872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T07:36:49Z","timestamp":1565768209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610114000872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1359610114000872"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2014.08.004","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Message in a bottle: lessons learned from antagonism of STING signalling during RNA virus infection","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2014.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}